Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cells.

by Miho Nara, Kazuaki Teshima, Atsushi Watanabe, Mitsugu Ito, Keiko Iwamoto, Atsushi Kitabayashi, Masaaki Kume, Yoshiaki Hatano, Naoto Takahashi, Shinsuke Iida, Kenichi Sawada, Hiroyuki Tagawa
Published 2013-01-01

Multiple Myeloma–Associated Ig Light Chain Crystalline Cast Nephropathy

by Hirotoshi Matsumura, Yusuke Furukawa, Takashi Nakagaki, Chikako Furutani, Sayaka Osanai, Keiichi Noguchi, Masafumi Odaka, Masafumi Yohda, Hiroshi Ohtani, Yoshihiro Michishita, Yoshinari Kawabata, Atsushi Kitabayashi, Sho Ikeda, Mizuho Nara, Atsushi Komatsuda, Naoto Takahashi, Hideki Wakui
Published 2020-09-01